Hospira Drug Shortage Suit Must Be Revived, 11th Circ. Told

By Erica Teichert (January 4, 2013, 8:03 PM EST) -- A putative class of individuals affected by Hospira Inc.'s decision to stop producing an injectable vitamin supplement on Thursday urged the Eleventh Circuit to revive their suit, alleging other companies may stop producing life-saving drugs if they don't face the threat of similar litigation....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Attached Documents

Related Sections

Law Firms


Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!